Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274547 · ClinicalTrials.gov registry record · Phase 3
Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Phase 3 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,829
- Enrollment target
NCT00274547: Completed Phase 3 study, sponsored by Boehringer Ingelheim.
NCT00274547 is a Phase 3 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 1,829 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (137% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00274547, a Phase 3 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,829 participants
- Enrollment target
Study Summary
The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacerbation and the proportion of patients hospitalized for an exacerbation during a six month observation period.
Interventions
- DRUG Tiotropium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,829 participants |
| Start Date | 2001-09 |
| Phase | Phase 3 |
What the finished NCT00274547 record still lists
NCT00274547 is an interventional study that assigns participants to a tested intervention. Its 1,829 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (137% higher).
The record links to 0 conditions, and to 1 intervention - of which Tiotropium is the first listed.
NCT00274547 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00274547 about?
NCT00274547 is a clinical study titled "Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)". The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacerbation and the proportion of patients hospitalized for an exacerbation during a six month observatio...
What is the current status of trial NCT00274547?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,829 participants. The study started on 2001-09.
What interventions are being tested in trial NCT00274547?
The interventions under investigation include: Tiotropium (DRUG).
Who is sponsoring clinical trial NCT00274547?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00274547's enrollment target sits among peer trials
1,829 117th of 2000 higher than 1,884 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia